HomeGLAND ⢠NSE
add
Gland Pharma Ltd
Previous close
âı1,735.60
Day range
âı1,736.00 - âı1,811.20
Year range
âı1,382.30 - âı2,131.00
Market cap
295.44B INR
Avg Volume
78.04K
P/E ratio
34.91
Dividend yield
1.00%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 16.95B | 22.49% |
Operating expense | 7.37B | 22.29% |
Net income | 2.61B | 27.74% |
Net profit margin | 15.42 | 4.26% |
Earnings per share | 16.98 | 36.68% |
EBITDA | 4.17B | 20.90% |
Effective tax rate | 27.79% | â |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.02B | 9.26% |
Total assets | â | â |
Total liabilities | â | â |
Total equity | 95.63B | â |
Shares outstanding | 164.76M | â |
Price to book | 2.99 | â |
Return on assets | â | â |
Return on capital | 8.29% | â |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.61B | 27.74% |
Cash from operations | â | â |
Cash from investing | â | â |
Cash from financing | â | â |
Net change in cash | â | â |
Free cash flow | â | â |
About
Founded
1978
Website
Employees
4,351
